MARKET

VTRS

VTRS

Viatris Inc Ord Shs
NASDAQ
17.76
-0.06
-0.34%
After Hours: 17.76 0 0.00% 16:04 07/30 EDT
OPEN
17.63
PREV CLOSE
17.82
HIGH
17.79
LOW
17.50
VOLUME
5.80M
TURNOVER
--
52 WEEK HIGH
18.07
52 WEEK LOW
8.30
MARKET CAP
20.68B
P/E (TTM)
-68.5979
1D
5D
1M
3M
1Y
5Y
1D
What Viatris (VTRS)'s FDA Approval of Weekly Gwyn Lo Contraceptive Patch Means For Shareholders
Simply Wall St · 13h ago
Viatris gains approval of Gwyn Lo contraceptive patch
Seeking Alpha · 1d ago
Viatris receives FDA approval for Gwyn Lo contraceptive patch
TipRanks · 1d ago
Viatris Secures FDA Approval For Gwyn Lo Contraceptive Patch
NASDAQ · 1d ago
VIATRIS - EXPECTS GWYN LO TO BE AVAILABLE LATER THIS YEAR
Reuters · 1d ago
Viatris Receives U.S. FDA Approval for Gwyn Lo™, a Once-Weekly Contraceptive Patch
PR Newswire · 1d ago
18 Ideal 'Safer' Buyable July Dogs Emerge After 10 Years Of Digging
Seeking Alpha · 1d ago
J.P. Morgan Sticks to Its Hold Rating for Viatris (VTRS)
TipRanks · 2d ago
More
About VTRS
Viatris Inc. is a global healthcare company. The Company markets branded and generic drugs, including complex drugs. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. Its Developed Markets segment comprises its operations primarily in North America and Europe. The Company's Greater China segment includes its operations in mainland China, Taiwan and Hong Kong. The Company's JANZ segment consists of its operations in Japan, Australia and New Zealand. Its Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies including in Asia, Africa, Eastern Europe, Latin America and the Middle East as well as the Company's ARV franchise. It produces medicines for patients across a broad range of major therapeutic areas. From cardiovascular health to oncology, it offers treatment options across more than 10 major therapeutic areas covering a variety of noncommunicable and infectious diseases.

Webull offers Viatris Inc stock information, including NASDAQ: VTRS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VTRS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VTRS stock methods without spending real money on the virtual paper trading platform.